These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1533999

  • 1. Acquired resistance of MAI to clarithromycin.
    Ruf B, Schürmann D, Mauch H.
    Am Rev Respir Dis; 1992 May; 145(5):1241-2. PubMed ID: 1533999
    [No Abstract] [Full Text] [Related]

  • 2. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
    Dautzenberg B, Truffot C, Legris S, Meyohas MC, Berlie HC, Mercat A, Chevret S, Grosset J.
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):564-9. PubMed ID: 1832527
    [Abstract] [Full Text] [Related]

  • 3. Clarithromycin monotherapy of MAC-mycobacteriosis in AIDS patients.
    Weits J, Sprenger HG, Ilic P, van Klingeren B, Steensma JT.
    Neth J Med; 1991 Aug; 39(1-2):126-7. PubMed ID: 1835763
    [No Abstract] [Full Text] [Related]

  • 4. New antibiotics look good against M. avium.
    Am J Nurs; 1992 Jan; 92(1):12. PubMed ID: 1309625
    [No Abstract] [Full Text] [Related]

  • 5. Promising investigational drug available to AIDS patients.
    Bol Asoc Med P R; 1991 Nov; 83(11):508-9. PubMed ID: 1839821
    [No Abstract] [Full Text] [Related]

  • 6. Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
    de Lalla F, Maserati R, Scarpellini P, Marone P, Nicolin R, Caccamo F, Rigoli R.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1567-9. PubMed ID: 1387303
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.
    Doucet-Populaire F, Truffot-Pernot C, Grosset J, Jarlier V.
    J Antimicrob Chemother; 1995 Jul; 36(1):129-36. PubMed ID: 8537260
    [Abstract] [Full Text] [Related]

  • 9. In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex.
    Naik S, Ruck R.
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1614-6. PubMed ID: 2817858
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
    Pierce M, Crampton S, Henry D, Heifets L, LaMarca A, Montecalvo M, Wormser GP, Jablonowski H, Jemsek J, Cynamon M, Yangco BG, Notario G, Craft JC.
    N Engl J Med; 1996 Aug 08; 335(6):384-91. PubMed ID: 8663871
    [Abstract] [Full Text] [Related]

  • 11. Acquired resistance to clarithromycin as combined therapy in Mycobacterium avium intracellulare infection.
    De Wit S, D'Abbraccio M, De Mol P, Clumeck N.
    Lancet; 1993 Jan 02; 341(8836):53-4. PubMed ID: 8093299
    [No Abstract] [Full Text] [Related]

  • 12. Clarithromycin-induced thrombocytopenia.
    Price TA, Tuazon CU.
    Clin Infect Dis; 1992 Sep 02; 15(3):563-4. PubMed ID: 1387810
    [No Abstract] [Full Text] [Related]

  • 13. Disseminated Mycobacterium avium complex infection.
    Inderlied CB, Kemper CA.
    AIDS Clin Rev; 1992 Sep 02; ():131-72. PubMed ID: 1606056
    [No Abstract] [Full Text] [Related]

  • 14. The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study.
    Hosono Y, Kitada S, Yano Y, Mori M, Miki K, Miki M, Yoshimura K, Kagawa H, Oshitani Y, Yokota S.
    J Infect Chemother; 2018 May 02; 24(5):353-357. PubMed ID: 29361415
    [Abstract] [Full Text] [Related]

  • 15. Are strains of Mycobacterium avium more drug resistant when isolated from human immunodeficiency virus-infected patients?
    Hoffner SE.
    J Infect Dis; 1992 Jan 02; 165(1):179-80. PubMed ID: 1727889
    [No Abstract] [Full Text] [Related]

  • 16. Mycobacterium avium disease: progress at last.
    Bates JH.
    Am J Respir Crit Care Med; 1996 Jun 02; 153(6 Pt 1):1737-8. PubMed ID: 8665029
    [No Abstract] [Full Text] [Related]

  • 17. Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.
    Komiya K, Kurashima A, Ihi T, Nagai H, Matsumoto N, Mizunoe S, Ishii H, Takahashi O, Ohta K, Kudoh S, Kadota J.
    Int J Antimicrob Agents; 2014 Aug 02; 44(2):131-5. PubMed ID: 24948577
    [Abstract] [Full Text] [Related]

  • 18. [Activity of antibiotics against pigmented and unpigmented variants of Mycobacterium avium-intracellulare].
    Gevaudan MJ, Bollet C, Mallet MN, de Micco P.
    Pathol Biol (Paris); 1991 May 02; 39(5):429-35. PubMed ID: 1652731
    [Abstract] [Full Text] [Related]

  • 19. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.
    Wallace RJ, Brown BA, Griffith DE, Girard WM, Murphy DT, Onyi GO, Steingrube VA, Mazurek GH.
    Am J Respir Crit Care Med; 1994 May 02; 149(5):1335-41. PubMed ID: 8173775
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex.
    Inderlied CB, Kolonoski PT, Wu M, Young LS.
    J Infect Dis; 1989 May 02; 159(5):994-7. PubMed ID: 2540252
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.